Trial
NCT00040157
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
—
Condition
HIV Infections
Intervention
ACH126-443 (Beta-L-Fd4C)
Why stopped
Safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-30